Granules India (GRANULES)₹799.20−0.17%Pharmaceuticals
In the Jun 2026 quarter (consolidated), Granules India reported sales of ₹1,472 Cr, up 22.3% from Jun 2025, and net profit of ₹179 Cr, up 59.3% year on year. For the year to Mar 2026, sales were ₹5,343 Cr and net profit ₹593 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,185 | 1,152 | 1,172 | 1,176 | 964 | 1,134 | 1,192 | 1,204 | 1,293 | 1,382 | 1,465 | 1,472 |
| Expenses | 976 | 904 | 919 | 920 | 762 | 906 | 945 | 962 | 1,018 | 1,079 | 1,117 | 1,137 |
| Operating Profit | 213 | 250 | 256 | 260 | 203 | 231 | 253 | 248 | 279 | 309 | 353 | 340 |
| OPM % | 17.9% | 21.9% | 22.0% | 21.9% | 20.9% | 19.9% | 20.9% | 19.9% | 20.9% | 22.0% | 24.0% | 23.0% |
| Other Income | 2.01 | 1.01 | 2.01 | 2.01 | 3.01 | 6.02 | 33.05 | −10.02 | −1.01 | −4.01 | 25.07 | 2.01 |
| Interest | 26.03 | 29.04 | 29.03 | 27.01 | 26.03 | 27.01 | 24.04 | 24.01 | 29.01 | 29.04 | 33.05 | 21.02 |
| Depreciation | 53.21 | 52.19 | 53.16 | 53.16 | 53.15 | 57.22 | 64.18 | 69.20 | 72.20 | 74.32 | 82.27 | 80.29 |
| Profit before tax | 136 | 170 | 176 | 181 | 128 | 153 | 198 | 145 | 176 | 202 | 262 | 240 |
| Tax % | 25.0% | 26.1% | 26.1% | 26.1% | 24.1% | 23.1% | 23.0% | 22.0% | 26.0% | 26.1% | 23.0% | 25.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.99 | −19.01 | 0.00 | 0.00 | 12.01 | 0.00 |
| Net Profit | 102 | 126 | 130 | 135 | 96.69 | 118 | 152 | 113 | 130 | 150 | 201 | 179 |
| EPS (Rs) | 4.22 | 5.20 | 5.37 | 5.57 | 4.02 | 4.86 | 6.29 | 4.65 | 5.40 | 6.21 | 8.15 | 7.28 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,351 | 1,405 | 1,680 | 2,272 | 2,589 | 3,224 | 3,748 | 4,496 | 4,490 | 4,463 | 5,343 | 5,612 |
| Expenses | 1,079 | 1,112 | 1,406 | 1,892 | 2,070 | 2,381 | 3,033 | 3,595 | 3,645 | 3,533 | 4,171 | 4,352 |
| Operating Profit | 276 | 300 | 279 | 385 | 527 | 858 | 728 | 916 | 859 | 950 | 1,191 | 1,280 |
| OPM % | 19.9% | 21.0% | 16.9% | 16.9% | 19.9% | 25.9% | 18.9% | 20.0% | 19.0% | 20.9% | 22.0% | 22.8% |
| Other Income | 5.01 | 35.06 | 27.04 | 75.16 | 90.18 | 26.07 | 13.02 | 12.03 | 2.01 | 41.06 | 7.02 | 22.06 |
| Interest | 37.01 | 32.02 | 33.01 | 28.01 | 27.02 | 26.03 | 23.01 | 56.01 | 106 | 103 | 114 | 112 |
| Depreciation | 58.19 | 72.31 | 76.21 | 105 | 137 | 152 | 160 | 185 | 208 | 227 | 297 | 309 |
| Profit before tax | 186 | 230 | 196 | 326 | 451 | 705 | 558 | 687 | 547 | 660 | 785 | 880 |
| Tax % | 33.0% | 28.0% | 32.0% | 27.0% | 26.0% | 22.0% | 26.0% | 25.0% | 26.1% | 24.0% | 24.0% | — |
| Exceptional items | 0.00 | 1.01 | 0.00 | 0.00 | 20.01 | 0.00 | −4.01 | −0.99 | −2.01 | 35.99 | −10.01 | 12.01 |
| Net Profit | 123 | 164 | 133 | 235 | 334 | 547 | 412 | 515 | 404 | 500 | 593 | 660 |
| EPS (Rs) | 5.69 | 7.21 | 5.24 | 9.33 | 13.22 | 22.23 | 16.69 | 21.38 | 16.78 | 20.74 | 24.06 | 27.04 |
| Dividend payout % | 11.0% | 13.0% | 19.1% | 11.1% | 8.0% | 7.0% | 9.0% | 7.0% | 9.0% | 7.0% | 7.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19.92 | 21.91 | 22.90 | 24.91 | 24.89 | 24.89 | 24.90 | 24.91 | 23.89 | 23.91 | 23.89 | 24.90 |
| Reserves | 412 | 640 | 881 | 1,279 | 1,505 | 1,818 | 2,148 | 2,562 | 2,809 | 3,203 | 3,691 | 5,062 |
| Borrowings | 482 | 640 | 656 | 977 | 990 | 891 | 848 | 1,105 | 1,134 | 1,314 | 1,454 | 1,511 |
| Other Liabilities | 288 | 259 | 317 | 386 | 456 | 485 | 687 | 815 | 928 | 952 | 1,046 | 1,081 |
| Total Liabilities | 1,202 | 1,561 | 1,877 | 2,668 | 2,976 | 3,220 | 3,707 | 4,507 | 4,894 | 5,493 | 6,216 | 7,679 |
| Fixed Assets | 618 | 561 | 645 | 778 | 946 | 1,206 | 1,335 | 1,544 | 1,913 | 2,101 | 2,431 | 3,258 |
| CWIP | 62.01 | 77.03 | 267 | 515 | 497 | 294 | 239 | 356 | 239 | 272 | 441 | 410 |
| Investments | 0.00 | 69.78 | 108 | 157 | 210 | 18.95 | 18.96 | 19.96 | 20.93 | 21.93 | 21.96 | 0.99 |
| Other Assets | 522 | 853 | 856 | 1,218 | 1,323 | 1,701 | 2,114 | 2,586 | 2,721 | 3,099 | 3,322 | 4,010 |
| Inventories | 225 | 253 | 268 | 279 | 383 | 437 | 780 | 977 | 1,147 | 1,298 | 1,340 | 1,669 |
| Trade receivables | 137 | 375 | 418 | 628 | 675 | 662 | 765 | 925 | 949 | 986 | 943 | 909 |
| Cash & equivalents | 65.16 | 130 | 50.10 | 116 | 89.15 | 285 | 272 | 409 | 314 | 387 | 597 | 950 |
| Total Assets | 1,202 | 1,561 | 1,877 | 2,668 | 2,976 | 3,220 | 3,707 | 4,507 | 4,894 | 5,493 | 6,216 | 7,679 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 149 | 150 | 187 | −0.99 | 261 | 474 | 431 | 331 | 736 | 437 | 864 | 791 |
| Cash from investing activity | −146 | −162 | −326 | −462 | −270 | −160 | −277 | −379 | −192 | −358 | −689 | −758 |
| Cash from financing activity | 19.07 | 86.28 | 56.16 | 531 | −17.04 | −214 | −300 | 191 | −441 | 8.02 | −93.28 | 380 |
| Net cash flow | 24.02 | 75.04 | −82.01 | 66.05 | −25.01 | 103 | −144 | 143 | 107 | 90.07 | 84.99 | 414 |
| Capex | 148 | 162 | 316 | 445 | 278 | 184 | 270 | 397 | 410 | 380 | 570 | 556 |
| Free cash flow | 3.01 | −10.03 | −127 | −448 | −17.04 | 293 | 161 | −65.17 | 328 | 61.15 | 298 | 240 |
| CFO / OP % | 87.0% | 72.0% | 83.0% | 21.0% | 91.0% | 113.0% | 73.0% | 66.0% | 100.0% | 73.0% | 107.0% | 87.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 39 | 101 | 108 | 136 | 108 | 93 | 86 | 90 | 77 | 80 | 77 | 62 |
| Inventory days | 110 | 128 | 145 | 114 | 112 | 125 | 205 | 190 | 182 | 235 | 284 | 326 |
| Days payable | 91 | 90 | 115 | 111 | 93 | 101 | 141 | 123 | 123 | 134 | 153 | 130 |
| Cash conversion cycle | 56 | 137 | 136 | 137 | 125 | 115 | 149 | 155 | 134 | 178 | 206 | 255 |
| Working capital days | 6 | 9 | −2 | 42 | 48 | 63 | 62 | 44 | 36 | 35 | 42 | 49 |
| ROCE % | 19.0% | 20.0% | 18.0% | 12.0% | 15.0% | 17.0% | 25.0% | 17.0% | 19.0% | 15.0% | 15.0% | 16.0% |
For the Jun 2026 quarter, Granules India reported sales of ₹1,472 Cr, up 22.3% year on year and net profit of ₹179 Cr, up 59.3% year on year. The operating margin was 23.0%.
Granules India's sales for the year to Mar 2026 were ₹5,343 Cr; over the last twelve months they were ₹5,612 Cr.
Net profit for the year to Mar 2026 was ₹593 Cr, and ₹660 Cr over the last twelve months. Earnings per share over the same trailing period were ₹27.04.
Granules India reported borrowings of ₹1,511 Cr at Mar 2026, against cash and equivalents of ₹950 Cr.
Cash from operations was ₹791 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹240 Cr.